A Comprehensive Review on Clinical Trials

Author:

Ashwini B. Zade 1,Sanjay K Bais 1,Simran Nadaf 1

Affiliation:

1. Fabtech College of Pharmacy, Sangola, Maharashtra, India

Abstract

A clinical trial is an inquiry carried out on human participants in order to investigate specific medical-related questions. The Clinical trials are the most efficient and secure way to improve a patient's health and find a medication that works for them. In a controlled environment, investigational studies determine the safety and effectiveness of new therapeutic modalities or experimental treatments. Health issues in large populations or groups in their natural settings are the focus of observational studies. A major and highly specialised kind of biological experiment used to gauge a treatment's effectiveness is called a clinical trial. Phase I pharmacokinetics, safety, and gross effects are investigated by clinical pharmacologists on human subjects. If the medication passes the test, it advances to phase II trials, where clinical pharmacologists examine the safety, therapeutic efficacy, and pharmacokinetics of the medication on a patient subset. Hundreds of these patients are subsequently examined in phase III trials, primarily for safety and therapeutic efficacy, if the drug is approved. The medication is now authorized and on the market if this is approved. Even after the treatment has been put on the market, doctors from various clinics and hospitals still offer their assessments of it, including how effective it is in phase. 4[1].

Publisher

Naksh Solutions

Subject

General Medicine

Reference11 articles.

1. Nayak C, Baig H, Ch R, Oberai P, Varanasi R, Reddy.. A multicentre, prospective, open-label study evaluating homeopathic treatment of diabetic distal symmetric polyneuropathy. 2013; In Homeopathy 102: 130–8.

2. Thorne JC, Kuriya B, Larché M, Bykerk VP, Keystone EC and Haraoui B. Learning from clinical trial data to improve clinical practice. Rheumatology Clinical Research 2013; in press

3. Clinical research can be accessed at http://www.nhmrc.gov.au/health-ethics/huma n-research-ethics. Evilauction dated April 15, 2013.

4. "Lancet" (2009). "Phase 0 Trials: A Drug Development Platform?". Lancet. 374(9685):176-118

5. Yang, Z. J., et al. (2010). “Incentives for health information seeking and registration success.” Health Communication 25(5): 423-436.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3